LENZ Therapeutics, Inc. (LENZ) Misses Q3 EPS by 59c

LENZ Therapeutics, Inc. (NASDAQ: LENZ) reported Q3 EPS of ($0.59). Revenue for the quarter came in at $12.5 million.

For earnings history and earnings-related data on LENZ Therapeutics, Inc. (LENZ) click here.

You May Also Be Interested In

• Senate votes to halt Iran war unless Trump gets approval from Congress
• Tellus Power and Nayax partner on integrated EV charging platform
• Genco Shipping & Trading Limited (GNK) 8400 contracts of August 30 calls trade, share price up 5.5%